Cart
sales@molnova.com
SB269970 HCl
CAS No. 261901-57-9
SB269970 HCl( SB-269970A )
Catalog No. M17459 CAS No. 261901-57-9
SB269970 HCl, a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 149 | In Stock |
|
| 5MG | 86 | In Stock |
|
| 10MG | 135 | In Stock |
|
| 25MG | 268 | In Stock |
|
| 50MG | 389 | In Stock |
|
| 100MG | 720 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSB269970 HCl
-
NoteResearch use only, not for human use.
-
Brief DescriptionSB269970 HCl, a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors.
-
DescriptionSB269970 HCl, a hydrochloride salt form of SB-269970, is a 5-HT7 receptor antagonist (pKi of 8.3) and exhibits >50-fold selectivity against other receptors.
-
In Vitro——
-
In VivoSB269970 hydrochloride (SB-269970A) (3-30 mg/kg; i.p.; once) significantly blocks amphetamine and ketamine-induced hyperactivity. Animal Model:Male C57BL6/J miceDosage:3, 10, 30 mg/kg Administration:Intraperitoneal injection; onceResult:Significantly blocked amphetamine and ketamine-induced hyperactivity.
-
SynonymsSB-269970A
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
Recptor5-HT7
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number261901-57-9
-
Formula Weight388.95
-
Molecular FormulaC18H28N2O3S·HCl
-
Purity>98% (HPLC)
-
SolubilityDMSO : ≥ 30 mg/mL; 77.13 mM
-
SMILESCl.CC1CCN(CC[C@H]2CCCN2S(=O)(=O)c2cccc(O)c2)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hagan JJ, et al. Br J Pharmacol, 2000, 130(3), 539-548.
molnova catalog
related products
-
Pico145
Pico145 is a remarkable inhibitor of TRPC1/4/5 channels. Pico145 inhibits (?)-englerin A-activated TRPC4/TRPC5 channels.
-
Elismetrep
Elismetrep (MT-8554) is an orally available TRPM8 inhibitor with potential analgesic activity for the study of vasomotor symptoms in postmenopausal women.
-
Pyr6
Pyr6 is a selective TRPC3 inhibitor with IC50 of 0.49 uM(Ca2+ influx inhibition in thapsigargin depleted native RBL-2H3 cells).Pyr6 is an inhibitor of Ca2+ entry, which displays higher potency to inhibit Ca2+ entry mediated by CRAC channel than by TRPC3.Pyr3 is selective inhibitor of TRPC3, inhibited Orai1- and TRPC3-mediated Ca(2+) entry and currents as well as mast cell activation with similar potency.?
